EU

EU SLAPS TEVA WITH €462 MILLION FINE FOR ANTI-COMPETITIVE TACTICS IN MS DRUG MARKET

In a landmark decision, the European Commission fined Teva Pharmaceuticals 462.6 million euros for leveraging its dominant position to delay the market entry of competitor treatments for multiple sclerosis (MS). The fine addresses both Teva's manipulation of patent protections and its misleading marketing tactics,...

DECODING THE SIGNIFICANCE OF THE EUROPEAN COURT’S LANDMARK RULING IN GOOGLE SHOPPING ANTITRUST CASE

The European Union's highest court has dismissed Google's appeal regarding a ruling on abuse of dominance and a penalty of €2.42 billion in the Google Shopping case. The European Court of Justice upheld the decision that Google abused its dominant position by prioritizing its...
spot_img

Keep exploring

No posts to display

Latest articles

ALLERGAN BREAST IMPLANT LAWSUITS: KEY INSIGHTS INTO THE GROWING LEGAL BATTLE

In recent years, Allergan, the Ireland-based medical device manufacturer, has found itself at the...

EU SLAPS TEVA WITH €462 MILLION FINE FOR ANTI-COMPETITIVE TACTICS IN MS DRUG MARKET

In a landmark decision, the European Commission fined Teva Pharmaceuticals 462.6 million euros for...

DUTCH COURT DISMISSES SHAREHOLDER CLAIMS AGAINST PETROBRAS

On 30 October 2024, the Rotterdam district court ruled to dismiss claims by the...

COURT OF APPEAL TO RECONSIDER USE OF CPR 19.8 IN LANDMARK DATA PRIVACY CLASS ACTION

The Court of Appeal of England and Wales is reviewing an appeal by Andrew...